News & Trends - Pharmaceuticals
Monash backs UCB and Biogen’s first-in-class lupus drug
The first Phase 3 trial of UCB and Biogen’s anti-CD40L antibody in systemic lupus erythematosus (SLE) has delivered promising results, […]
MoreNews & Trends - MedTech & Diagnostics
Abbott’s leadless pacemaker now on Prescribed List
Abbott’s single chamber transcatheter leadless pacemaker is now listed on the Prescribed List (PL), broadening its access to privately insured […]
MoreNews & Trends - Pharmaceuticals
New biosimilars to hit PBS, but uptake still lags behind
Several biosimilars are set to be listed on the Pharmaceutical Benefits Scheme (PBS), despite the nation continuing to lag behind […]
MoreNews & Trends - MedTech & Diagnostics
The kidney cut-off: Why First Nations patients aren’t making the transplant list
Access to kidney transplantation continues to highlight significant disparities, particularly affecting Aboriginal and Torres Strait Islander populations who face a […]
More